Skip to main navigation Skip to search Skip to main content

Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma

  • Cristian Aguilar
  • , Brady E. Beltran
  • , Domingo Morales
  • , Marco Gutiérrez-Garibay
  • , Luis Villela
  • , Mario L. Marques-Piubelli
  • , Francisco Vega
  • , Roberto N. Miranda
  • , Luis Malpica
  • Instituto Nacional Cardiovascular Carlos Alberto Peschiera Carrillo, EsSalud
  • Hospital Nacional Edgardo Rebagliati Martins (HNERM)
  • Universidad de San Martín de Porres
  • Hospital Nacional Hipolito Unanue
  • Hospital General “Dr. Fernando Ocaranza” - Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE)
  • University of Texas MD Anderson Cancer Center

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is an aggressive mature T-cell neoplasm caused by infection with the Human T-cell Lymphotropic Virus Type 1 (HTLV-1). Cardiac involvement in patients with ATLL is infrequent, and when it happens it is usually seen in aggressive ATLL subtypes. However, ATLL presenting as isolated cardiac valve involvement is extremely rare. To date, only three histologically proven cases of ATLL with isolated cardiac valve involvement have been reported. Herein, we describe a 61-year-old Peruvian man who presented heart failure symptoms secondary to progressive cardiac valve infiltration. The patient underwent mitral valve replacement with a mechanical prosthesis. Histopathological evaluation of the resected valve revealed leaflet thickening with a nodular appearance due to fibrous tissue containing atypical T-lymphocytes with Foxp3 expression, infiltrating all layers of the resected valve. Interestingly, tumor cells were distributed around an incidental venous malformation (i.e., cavernous hemangioma). Postoperative evaluation demonstrated positive serology for HTLV-1, and a diagnosis of ATLL was established. Postoperative positron emission tomography/computed tomography did not show lesions outside the heart and cell blood counts were within normal range with low level of circulating CD4+ CD25+ lymphoma cell counts (7%); therefore, patient's disease was considered as smoldering ATLL and a “watch and wait” strategy was pursued. Currently, the patient is alive with no progression of disease after 18 months from diagnosis. Isolated cardiac valve involvement by ATLL should be considered in the differential diagnosis of HTLV-1 carriers with progressive heart failure, even when systemic lymphoma involvement is absent or not apparent.

Original languageEnglish
Article number107513
JournalCardiovascular Pathology
Volume64
DOIs
StatePublished - 1 May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adult T-cell leukemia/lymphoma
  • cardiac valve
  • HTLV-1
  • mitral valve

Fingerprint

Dive into the research topics of 'Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma'. Together they form a unique fingerprint.

Cite this